Search
Human interferon omega-1
go.drugbank.com/drugs/DB05472InvestigationalThe biological activities of IFN-omega 1 and its physiological role are not known to date. … Human interferon omega 1 (IFN-omega 1 = IFN-alpha II1) is a recently discovered protein structurally related to IFN-alpha and -beta.
Oxyphenisatin acetate
go.drugbank.com/drugs/DB14627ApprovedWithdrawnThe FDA withdrew its approval for the use of oxyphenisatin acetate due to safety reasons.[L43942]
NS-398
go.drugbank.com/drugs/DB14060ExperimentalNS-398 is a COX-2 inhibitor. It was developed as part of the mechanistic study of the cyclooxygenases.
Synonyms: N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamideMontmorillonite
go.drugbank.com/drugs/DB13654InvestigationalMixtures: SEED Teatree and Lime Vegan No-sebum Cool Anti HairlossShampooTST10088
go.drugbank.com/drugs/DB05151ExperimentalTST10088 has been designed and engineered by Twinstrand to contain a peptide switch that is specifically cleaved by the matrix metalloproteinases which are known to be involved in tumor growth and metastasis … TST10088 is a recombinant variant of a plant toxin belonging to the family of class II ribosome inactivating proteins.
Veligrotug
go.drugbank.com/drugs/DB18976Approveddepending on whether it is caught in the active inflammatory phase or has become chronic - Viridian describes veligrotug-vvze as the first approved treatment for the disease whose labeling includes data from
Nandrolone
go.drugbank.com/drugs/DB13169InvestigationalNandrolone, also known as 19-nortestosterone or 19-norandrostenolone, is a synthetic anabolic-androgenic steroid (AAS) derived from testosterone.
SPP1148
go.drugbank.com/drugs/DB05203ExperimentalSPP1148, the most promising compound from a new series of renin inhibitors for the treatment of hypertension and related end-organ disease.
RAPA-501-Allo
go.drugbank.com/drugs/DB15890InvestigationalRAPA-501-ALLO is composed of T-cells extracted from healthy volunteers; these cells are then reprogrammed _ex vivo_ in a process that involves de-differentiation and re-differentiation.[L16483]
Camostat
go.drugbank.com/drugs/DB13729Investigational[A198807] Camostat mesylate inhibits cholecystokinin, pro-inflammatory cytokines, and serine proteases, leading to it being investigated for multiple indications including the treatment of COVID-19.